E-LIB Suche - Ergebnisse für: Czyżewicz, Grzegorz

1

Pembrolizumab-combination therapy for NSCLC- effectiveness ..:

Knetki-Wróblewska, Magdalena ; Dziadziuszko, Rafał ; Jankowski, Tomasz...
Frontiers in Oncology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

2

Treatment Patterns, Testing Practices, and Outcomes in Pati..:

Pluzanski, Adam ; Bryl, Maciej ; Chmielewska, Izabela...
Cancers. 15 (2023) 5 - p. 1581 , 2023

Link: https://doi.org/10.3390/..

3

Detection of EGFR mutations in liquid biopsy samples using ..:

Szpechcinski, Adam ; Bryl, Maciej ; Wojcik, Piotr...
Advances in Medical Sciences. 66 (2021) 2 - p. 336-342 , 2021

Link: https://doi.org/10.1016/..

4

Oral vinorelbine and cisplatin as first-line therapy for ad..:

Grossi, Francesco ; Jaśkiewicz, Piotr ; Ferreira, Marion...
Therapeutic Advances in Medical Oncology. 13 (2021) - p. 175883592110229 , 2021

Link: https://doi.org/10.1177/..

5

Effectiveness of Osimertinib in Patients with Lung Adenocar..:

Knetki-Wróblewska, Magdalena ; Kowalski, Dariusz ; Czyżewicz, Grzegorz...
Advances in Respiratory Medicine. 88 (2020) 3 - p. 189-196 , 2020

Link: https://doi.org/10.5603/..

6

Altered fibrin clot properties in advanced lung cancer: str..:

Ząbczyk, Michał ; Królczyk, Grzegorz ; Czyżewicz, Grzegorz...
Medical Oncology. 36 (2019) 4 - p. , 2019

Link: https://doi.org/10.1007/..

7

The expression of circulating miR-504 in plasma is associat..:

Szpechcinski, Adam ; Florczuk, Mateusz ; Duk, Katarzyna...
Cellular and Molecular Life Sciences. 76 (2019) 18 - p. 3641-3656 , 2019

Link: https://doi.org/10.1007/..

8

Decreased Levels of Histidine-Rich Glycoprotein in Advanced..:

Winiarska, Aleksandra ; Zareba, Lech ; Krolczyk, Grzegorz...
Disease Markers. 2019 (2019) - p. 1-7 , 2019

Link: https://doi.org/10.1155/..

9

The comparison between Caprini and Padua VTE risk assessmen..:

Łukaszuk, Robert F. ; Dolna-Michno, Justyna ; Plens, Krzysztof..
Współczesna Onkologia. 22 (2018) 1 - p. 31-36 , 2018

Link: https://doi.org/10.5114/..

10

Efficacy and Safety of Ramucirumab With Docetaxel Versus Pl..:

Ramalingam, Suresh S. ; Pérol, Maurice ; Reck, Martin...
Clinical Lung Cancer. 19 (2018) 3 - p. 270-279.e3 , 2018

Link: https://doi.org/10.1016/..

11

Ocena wpływu chemioterapii na czas przeżycia i wybrane obja..:

Rolski, Janusz ; Zemełka, Tomasz ; Jasiówka, Marek..
Advances in Respiratory Medicine. 75 (2007) 4 - p. 343-348 , 2007

Link: https://doi.org/10.5603/..

12

Five-Year Outcomes From the Randomized, Phase III Trials Ch..:

Borghaei, Hossein ; Gettinger, Scott ; Vokes, Everett E...
http://hdl.handle.net/10668/16983. , 2021

Link: http://hdl.handle.net/10..

13

Oral vinorelbine and cisplatin as first-line therapy for ad..:

Grossi, Francesco ; Jaśkiewicz, Piotr ; Ferreira, Marion...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287271/. , 2021

Link: http://www.ncbi.nlm.nih...

14

Five-Year Outcomes From the Randomized, Phase III Trials Ch..:

Borghaei, Hossein ; Gettinger, Scott ; Vokes, Everett E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078445/. , 2021

Link: http://www.ncbi.nlm.nih...

15

Altered fibrin clot properties in advanced lung cancer : st..:

Ząbczyk, Michał ; Królczyk, Grzegorz ; Czyżewicz, Grzegorz...
Medical Oncology, T. 36, nr 4. , 2019

Link: https://ruj.uj.edu.pl/xm..